Single Cell Market Size Analysis, Stock & Trend Analysis Report By Product, By Application, By Workflow, By End User, By Region And Sector Forecast, 2022

ReportLinker

ReportLinker

Single-cell analysis of market size, stock analysis report and trends by product (consumables, tools), by application (cancer, immunology), by workflow, by end user, by region, and segment forecast, 2022-2030

NEW YORK, Sep 13, 2022 (GLOBE NEWSWIRE) – Reportlinker.com announces the release of ‘One Cell Analysis of Market Size, Stock Analysis and Trends Report by Product, By Application, By Workflow, By End User, By Region & Segment Forecast, 2022 – 2030’ “- https://www.reportlinker.com/p06318470/?utm_source=GNW

Single cell analysis, market growth and trends

The global single cell analysis market size is expected to reach US$ 15.22 billion by 2030. It is expanding at a CAGR of 18.5% from 2022 to 2030. Technological advances, expanding applications in cancer research, and higher government funding for cell-based research . The main drivers of the market. In addition, the market is advancing as a result of the COVID-19 pandemic. For example, in January 2021, according to the American Journal of Physiology, differences in mononuclear cellular profiles in peripheral blood of patients with COVID-19 were examined using single-cell analysis (SEA) by cytometry, which complemented the industry’s growth.

Government agencies around the world have increased funding for vaccine development and production in response to the economic and social costs of the ongoing pandemic, which has increased the use of SEA tools for COVID-19 research. Therapeutic approaches for people who are seriously ill, it is necessary to know the immune response of the host throughout the course of pathogenesis.

Therefore, the market is positively affected by COVID-19 because single cell analysis helps assess peripheral immune function in disease and makes new contributions to the study of disease pathophysiology and treatment possibilities.

The single-cell technology assists in the molecular level examination of pathways and processes as well as the assessment of cellular heterogeneity. This technology is rapidly evolving with uses in oncology, immunology, and other fields.

Furthermore, the development of sophisticated tools that make transcriptional and proteomic processes simpler enhances the use of SEA methods, as researchers are now able to comprehensively screen uncommon cell types that have not been studied previously due to developments in scRNAseq.

The application of single-cell genomic/transcriptional analysis in the field of biomedicine has been greatly expanded by the development of microfluidic technology. Moreover, cell dissociation and tissue digestion have been adapted to a wide range of microfluidic devices, which has increased the adoption of SEA technology and promoted the growth of the industry further.

The increased investment flow in research and development in this field is reflected in the increasing number of research publications, for example, in April 2020, a $2 million funding round headed by venture capital firm i & i Biotech Fund for Sampling Human, a life science guy. The tech startup that created a diagnostic platform that uses genetically modified cells to examine other cells in their environment (i & i Bio).

Moreover, research and development and business growth will be enhanced through investment. Moreover, these expenditures indicate a better growth opportunity for this market because research and development efforts serve as the basis for innovation.

In addition, scientists are analyzing geographic variation in gene expression profiles at the single-cell level, which is expected to increase demand for consumer materials and analysis equipment, thus driving industry growth.

Single Cell Market Report Highlights
• By product, the consumables segment accounted for the largest share of revenue in 2021. This segment is expected to be driven by extensive use of consumables in genetic research, exogenous analysis, and RNA and DNA isolation
• Based on application, the cancer segment captured the largest share of revenue in 2021. This segment is being driven by single cell analysis, which has proven successful in early cancer diagnoses. These techniques make it easy to determine cell types, mutation rates, and growth settings
• In terms of workflow, single cell isolation and library preparation segment captured the largest share of revenue in 2021. Increased research using single cell analysis is expected to drive revenue growth
• Based on the end user, the academic and research laboratories segment had the largest share of revenue in 2021. The widespread use of various SEA techniques in research environments has been influenced by a large number of ongoing research projects in academic institutions using SEA assays
• North America had the largest share of revenue in 2021. This is mostly due to significant market participants, increased spending on research and development and federal aid
• The Asia Pacific region is expected to grow at the highest rate during the forecast period due to factors such as increased prevalence of target diseases, an aging population, and increased adoption of single cell technology
Read the full report: https://www.reportlinker.com/p06318470/?utm_source=GNW

Around Reportlinker
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you have all the market research you need – instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Leave a Comment